Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries
- DOI
- 10.3389/fphar.2024.1369178
- Published
- 2024-03-08
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2024.1369178,
title = {Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries},
author = {Szczepan Jakubowski and Pawel Kawalec and Przemyslaw Holko and Iwona Kowalska-Bobko and Maria Kamusheva and Guenka Petrova and Pero Draganić and Leos Fuksa and Agnes Männik and Fanni Ispán and Vitalis Briedis and Ioana Bianchi and Marian Sorin Paveliu and Tomas Tesar},
year = {2024},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2024.1369178},
url = {https://doi.org/10.3389/fphar.2024.1369178}
}RIS
TY - JOUR TI - Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries AU - Szczepan Jakubowski AU - Pawel Kawalec AU - Przemyslaw Holko AU - Iwona Kowalska-Bobko AU - Maria Kamusheva AU - Guenka Petrova AU - Pero Draganić AU - Leos Fuksa AU - Agnes Männik AU - Fanni Ispán AU - Vitalis Briedis AU - Ioana Bianchi AU - Marian Sorin Paveliu AU - Tomas Tesar PY - 2024 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2024.1369178 UR - https://doi.org/10.3389/fphar.2024.1369178 ER -
APA
Jakubowski, S., Kawalec, P., Holko, P., Kowalska-Bobko, I., Kamusheva, M., Petrova, G., Draganić, P., Fuksa, L., Männik, A., Ispán, F., Briedis, V., Bianchi, I., Paveliu, M. S., & Tesar, T. (2024). Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2024.1369178
Source records
- crossref · retrieved 2026-09-27T10:43:10.777Z